The Filing Desk

Lucid Diagnostics vs Neuraxis

Lucid Diagnostics LUCD · Neuraxis NRXS · Health Care Equipment

Lucid Diagnostics reported revenue of $5 million in fiscal 2025, 1.3 times Neuraxis' $4 million in fiscal 2025. Lucid Diagnostics' revenue grew 8.3% in its latest year, and Neuraxis' grew 32.9%. Lucid Diagnostics had an operating margin of -1054.8%, against -219.4% at Neuraxis. Free cash flow was −$47 million at Lucid Diagnostics and −$6 million at Neuraxis.

Side by side

Lucid DiagnosticsNeuraxis
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$5M$4M
Revenue growth8.3%32.9%
Revenue growth a year, last 5 years——
Gross margin−41.7%84.2%
Operating margin−1,054.8%−219.4%
Net margin−1,232.7%−218.6%
Free cash flow−$47M−$6M
Free cash flow margin−992.0%−181.1%
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count101.8%31.3%
Last close$0.39$4.50
P/E at the last close——
Insider trades, last 12 monthsbought $245,000, sold $0bought $1.4 million, sold $0
Piotroski F-score——
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Lucid DiagnosticsNeuraxis
Operating margin
Percent of revenue
Lucid DiagnosticsNeuraxis
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Lucid DiagnosticsNeuraxis

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Lucid Diagnostics and Neuraxis pages.